Ensure Safe Use of OTC Primatene Mist for Asthma

Primatene Mist (epinephrine) will return to OTC shelves for relieving mild symptoms of intermittent asthma in patients age 12 and up.

It was withdrawn in 2011 due to chlorofluorocarbon (CFC) propellant regulations, NOT safety issues. But many of us were happy to see it go.

Now Primatene Mist is back with an HFA propellant.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote